文献速递临床试验与 GCP流行病学与生物统计

以患者为中心的实用性临床试验:开启DOOR范式

Patient-Centric Pragmatic Clinical Trials: Opening the DOOR.
PubMed 文献 · Stat Med · 2026-01-01

随机临床试验是评估干预获益与风险的金标准,但常无法提供医学决策所需证据,原因包括未识别最重要问题、传统方法未直接解决这些问题。本文描述DOOR(结局获益排序)范式的原理与方法,用于基于综合患者中心获益-风险评估进行试验设计、数据监查、分析、解释与报告,并提供免费在线工具。

要点

  • 传统单结局分析无法整合个体患者多个结局之间的关联或累积效应。
  • DOOR范式基于综合患者中心获益-风险评估进行试验设计与分析。
  • 提供免费在线工具用于实施DOOR的研究设计与分析。

核心结论

  • DOOR范式基于综合患者中心获益-风险评估,用于临床试验的设计、数据监查、分析、解释与报告,以解决传统方法的问题并推进临床试验科学。

研究设计与样本

  • 本文描述DOOR范式的设计原理与分析方法,并用一个示例说明,同时提供免费在线工具。
  • 随机临床试验是评估干预获益与风险的金标准,但常无法提供医学决策所需证据。

主要发现

  • 传统一次分析一个结局的方法未能纳入个体患者多个结局之间的关联或累积性质。
  • 传统方法在解释单个结局时受竞争风险复杂性影响,未能识别患者中心反应的重要分级。
  • 传统方法中疗效与安全性分析常在不同人群进行,导致获益:风险估计量和可推广性不明确。
  • 心血管事件预防试验通常使用MACE(如卒中、心肌梗死和死亡)作为主要终点,未能识别多个事件或事件的不同重要性。
  • 心血管事件预防试验通常使用相对风险模型,该模型依赖对稳健性有挑战的建模假设,在获益:风险和多结局评估中 contraindicated。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Randomized clinical trials are the gold standard for evaluating the benefits and harms of interventions, though they often fail to provide the necessary evidence to inform medical decision-making. Primary reasons are failure to recognize the most important questions for informing clinical practice, and that traditional approaches do not directly address these most important questions, and subsequently not using these most important questions as the motivation for the design, monitoring, analysis, and reporting of clinical trials. The standard approach of analyzing one outcome at a time fails to incorporate associations between or the cumulative nature of multiple outcomes in individual patients, suffers from competing risk complexities during interpretation of individual outcomes, fails to recognize important gradations of patient-centric responses, and since efficacy and safety analyses are often conducted on different populations, benefit:risk estimands and generalizability are unclear. Cardiovascular event prevention trials typically utilize: (1) major adverse cardiovascular events (MACE), for example, stroke, myocardial infarction, and death as the primary endpoint, which fails to recognize multiple events or the differential importance of events, and (2) relative risk models which rely on robustness-challenging modeling assumptions and are contraindicated in benefit:risk and multiple outcome evaluation. The Desirability Of Outcome Ranking (DOOR) is a paradigm for the design, data monitoring, analysis, interpretation, and reporting of clinical trials based on comprehensive patient-centric benefit:risk evaluation, developed to address these issues and advance clinical trial science. The rationale and the methodology for the design and analyses for the DOOR paradigm are described. The methods are illustrated using an example. Freely available online tools for the design and analysis of studies implementing the DOOR are provided.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Evans SR, Wu Q, Hamasaki T, et al. Patient-Centric Pragmatic Clinical Trials: Opening the DOOR. Stat Med. 2026. PMID: 41677577. doi:10.1002/sim.70328

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。